OncologyProESMO - Good science, better medicine, best practice

 
  • All
  • Clinical Trials
  • Drugs & Biologics
  • Webcasts
  • Monographs & Reviews
  • Biomarkers
  • Clinical Practice Guidelines
  • Targetscapes
  • Annals of Oncology
  • Esmo.org
  • News
  • e-Learning
  • Meeting Abstracts
  • Scientific Meeting Reports
  • Handbooks
  • Posters
  • Educational Books
  • Meeting Slides
  • Essentials for Clinicians
 
 

esmo.org

  • Oncology News
  • Research
    • Clinical Trials
    • Drugs & Biologics
    • Biomarkers
    • Targetscapes
  • Guidelines
    • Clinical Practice Guidelines
    • Consensus Statements
    • Guides for Patients
    • Mobile Guidelines
  • Publications & CME
    • Annals of Oncology
    • World Oncology Literature Service
    • Monographs & Reviews
    • Handbooks
    • Educational Books
    • e-Learning
    • Global Curriculum
    • Glossary of Molecular Biology
    • Meeting Abstracts
    • Essentials for Clinicians
  • Meeting Resources
    • Webcasts
    • Scientific Meeting Reports
    • Posters
    • Meeting Abstracts
    • Educational Books
    • Meeting Slides
  • Practice Tools
  • Slide Resources
    • ESMO Spotlights
    • Meeting Slides
    • Educational Slides
    >>
  • Home >
  • Meeting Resources >
  • Webcasts >
  • 2011 European Multidisciplinary Cancer Congress

2011 European Multidisciplinary Cancer Congress

2011 European Multidisciplinary Cancer Congress

24 - 27 September, 2011
Stockholm, Sweden

  1. 2010 Consensus on Lung Cancer: New Clinical Recommendations & Current Status of Biomarker Assessment
  2. Anti-Angiogenic Strategies for Cancer
  3. Basic Science/Translational Research
  4. ESMO Award session
  5. ESMO Clinical Practice Guidelines
  6. From New Targets to New Drugs in Prostate Cancer
  7. Head and Neck: What Next in Biologically Targeted Therapy?
  8. Hitting the Right Pathway: New Drugs for New Targets
  9. Is the Biology of Metastatic Breast Cancer Similar to the Primary Breast Cancer?
  10. Melanoma Therapy - Realising the Potential in Targeted Therapy
  11. Molecular Genetics in Lymphoma - Current Knowledge and New Insights From High-Throughput Technologies
  12. Presidential Session I: Best and Late Breaking Abstracts
  13. Presidential Session II: Best and Late Breaking Abstracts
  14. Scientific Symposium: Joint ESMO-JSMO Scientific Symposium on What Can We Learn From Global Clinical Trials?
  15. Treatment of Dyspnea - What Does the Evidence Support?
  16. Unravelling Ras PI3 Kinases Targets

Search within Webcasts

 
 

 

 
 
 
 
 
 

Spotlight

ESMO Guidelines: How deep we go in personalized medicine

Session: Guidelines

Congress: Personalized medicine 2013 - Signalling Pathways

01 - 02 March, 2013; Sitges, Spain

Most Viewed Webcasts

  • Breast cancer metastases and clinical progression clinical perspectives
  • Standard biomarkers
  • Sequencing
  • Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
  • Early phase proof of concept studies and rationale for patient selection
  • About ONCOLOGY PRO
  • About ESMO
  • Join ESMO
  • Contact Us
  • Conditions of Use
  • My ESMO
  • Sitemap
  • Sponsors

ESMO is a Swiss-registered not-for-profit organization. Funding for this site is provided directly by ESMO or via grants from the Sponsors.
Via L. Taddei 4, 6962 Viganello - Lugano - CH. © Copyright 2011 European Society for Medical Oncology. All rights reserved worldwide.

Close X
my esmo

Please Login

Invalid username/password.

Remember me!

loading

Forgot your Password?

Use of OncologyPRO is subject to the Conditions of Use

Not a member yet?

Discover myESMO